BACKGROUND:Haemodialysis patients are at high risk for cardiovascular (CV) events. The aim of the current study was to characterise the role of traditional and uraemia-specific CV risk factors in this patient population. METHODS: A post hoc analysis of the AURORA trial which enrolled 2,776 haemodialysis patients from 280 centres and had a mean follow-up period of 3.2 years. Determinants of CV endpoints (time to major cardiovascular event (MACE), cardiac event, CV death) were identified by univariate Cox regression analysis. Subsequently, independent determinants were identified by multivariate regression analysis. RESULTS: For the primary endpoint MACE (myocardial infarction, stroke and cardiac death), multivariate analysis revealed that independent determinants were: age (hazard ratio (HR) 1.03 per year), serum phosphate level (HR 1.50 per mmol/l), albumin level (HR 0.94 per g/l), years on haemodialysis (HR 1.03 per year), diabetes mellitus (HR 1.38), preexisting coronary heart disease (HR 1.54) and C-reactive protein (CRP) level (HR 1.14 per mg/l). However, conventional risk factors such as smoking, dyslipidaemia, systolic and diastolic blood pressure and pulse pressure had no significant effect. CONCLUSIONS: Although we identify CRP, low albumin, and high phosphorus as risk factors for MACE, lowering CRP did not influence MACE outcomes in our trial. Caution is therefore warranted in implying risk factors being causal in end-stage renal disease.
RCT Entities:
BACKGROUND: Haemodialysis patients are at high risk for cardiovascular (CV) events. The aim of the current study was to characterise the role of traditional and uraemia-specific CV risk factors in this patient population. METHODS: A post hoc analysis of the AURORA trial which enrolled 2,776 haemodialysis patients from 280 centres and had a mean follow-up period of 3.2 years. Determinants of CV endpoints (time to major cardiovascular event (MACE), cardiac event, CV death) were identified by univariate Cox regression analysis. Subsequently, independent determinants were identified by multivariate regression analysis. RESULTS: For the primary endpoint MACE (myocardial infarction, stroke and cardiac death), multivariate analysis revealed that independent determinants were: age (hazard ratio (HR) 1.03 per year), serum phosphate level (HR 1.50 per mmol/l), albumin level (HR 0.94 per g/l), years on haemodialysis (HR 1.03 per year), diabetes mellitus (HR 1.38), preexisting coronary heart disease (HR 1.54) and C-reactive protein (CRP) level (HR 1.14 per mg/l). However, conventional risk factors such as smoking, dyslipidaemia, systolic and diastolic blood pressure and pulse pressure had no significant effect. CONCLUSIONS: Although we identify CRP, low albumin, and high phosphorus as risk factors for MACE, lowering CRP did not influence MACE outcomes in our trial. Caution is therefore warranted in implying risk factors being causal in end-stage renal disease.
Authors: Annemarie Aarup; Carsten H Nielsen; Line S Bisgaard; Ilze Bot; Henrik H El-Ali; Andreas Kjaer; Lars B Nielsen; Tanja X Pedersen Journal: Sci Rep Date: 2017-07-26 Impact factor: 4.379
Authors: Konstantinos Sechidis; Konstantinos Papangelou; Paul D Metcalfe; David Svensson; James Weatherall; Gavin Brown Journal: Bioinformatics Date: 2018-10-01 Impact factor: 6.937
Authors: Larry A Weinrauch; Brian Claggett; Jiankang Liu; Peter V Finn; Matthew R Weir; Daniel E Weiner; John A D'Elia Journal: Int J Nephrol Renovasc Dis Date: 2018-04-27
Authors: David de Gonzalo-Calvo; Pablo Martínez-Camblor; Christian Bär; Kevin Duarte; Nicolas Girerd; Bengt Fellström; Roland E Schmieder; Alan G Jardine; Ziad A Massy; Hallvard Holdaas; Patrick Rossignol; Faiez Zannad; Thomas Thum Journal: Theranostics Date: 2020-07-09 Impact factor: 11.556
Authors: Sophie Girerd; Nicolas Girerd; Luc Frimat; Hallvard Holdaas; Alan G Jardine; Roland E Schmieder; Bengt Fellström; Nicla Settembre; Sergei Malikov; Patrick Rossignol; Faiez Zannad Journal: Clin Kidney J Date: 2019-05-11